Establishment of Immunodeficient Retinal Degeneration Model Mice and Functional Maturation of Human ESC-Derived Retinal Sheets after Transplantation

DOI IR HANDLE Web Site Web Site 11 Citations 49 References Open Access

Abstract

Increasing demand for clinical retinal degeneration therapies featuring human ESC/iPSC-derived retinal tissue and cells warrants proof-of-concept studies. Here, we established two mouse models of end-stage retinal degeneration with immunodeficiency, NOG-rd1-2J and NOG-rd10, and characterized disease progress and immunodeficient status. We also transplanted human ESC-derived retinal sheets into NOG-rd1-2J and confirmed their long-term survival and maturation of the structured graft photoreceptor layer, without rejection or tumorigenesis. We recorded light responses from the host ganglion cells using a multi-electrode array system; this result was consistent with whole-mount immunostaining suggestive of host-graft synapse formation at the responding sites. This study demonstrates an application of our mouse models and provides a proof of concept for the clinical use of human ESC-derived retinal sheets.

Journal

  • Stem Cell Reports

    Stem Cell Reports 10 (3), 1059-1074, 2018-03-01

    International Society for Stem Cell Research|Cell Press

Citations (11)*help

See more

References(49)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top